Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 534
Rev. argent. salud publica ; 10(38): 34-37, Abril 2019.
Article in Spanish | LILACS (Americas), BINACIS, ARGMSAL | ID: biblio-996478


El linfedema es una acumulación de linfa y tejido fibroadiposo anormal en los miembros. Su origen más habitual, en Argentina, es el tratamiento del cáncer de mama. El manejo incluye múltiples intervenciones, que van desde terapias no invasivas hasta técnicas quirúrgicas específicas. El objetivo de este informe fue evaluar la eficacia y seguridad de intervenciones destinadas al manejo del linfedema mediante la revisión de la evidencia científica disponible, con el fin de orientar la toma de decisiones de cobertura. Se realizó una búsqueda bibliográfica y se utilizó la lista de cotejo de PRISMA para la evaluación de revisiones sistemáticas. En caso de discrepancias, se consultó a un tercer revisor. Se recuperaron 141 trabajos a través de las distintas estrategias de búsqueda, 45 fueron evaluados mediante resumen o texto completo. Finalmente se incluyeron 10 revisiones sistemáticas. La evidencia para las intervenciones evaluadas resultó de baja confianza, principalmente por la presencia de estudios con escaso número de pacientes, comparadores distintos del manejo habitual, heterogeneidad en las intervenciones y tiempos acotados de seguimien

Humans , Radiotherapy , General Surgery , Therapeutics , Lymphedema , Neoplasms
Rev. bras. cir. plást ; 34(1): 113-119, jan.-mar. 2019. tab
Article in Portuguese | LILACS (Americas) | ID: biblio-994561


Este estudo objetivou analisar, por meio de uma revisão sistemática da literatura, a influência da reconstrução imediata na prevalência de linfedema após mastectomia em pacientes portadoras de câncer de mama. Foram analisados os mais relevantes estudos publicados originalmente em qualquer idioma até agosto de 2018, indexados às bases de dados US National Library of Medicine, Cochrane Central Register of Controlled Trials, Web of Science e Scientific Electronic Library Online. A amostra foi composta por 10 publicações que se adequaram aos critérios de inclusão e exclusão estabelecidos, incluindo 2.425 pacientes submetidas a apenas mastectomia e 2.772 pacientes submetidas à mastectomia associada à reconstrução imediata da mama. A prevalência de linfedema foi 20,95% nas pacientes submetidas a apenas mastectomia (n = 508) e de 5,23% nas pacientes submetidas à mastectomia associada à reconstrução imediata (n = 145), havendo diferença estatisticamente significativa (p < 0,001). Concluiu-se que a mastectomia associada à reconstrução imediata influencia positivamente o prognóstico das pacientes portadoras de câncer de mama, proporcionando um índice significativamente menor de linfedema, quando comparada à realização de apenas mastectomia.

This study aimed to analyze, through systematic review of literature, the influence of immediate reconstruction on the prevalence of lymphedema after mastectomy, in women living with breast cancer. The analysis considered the most relevant studies originally published, in any language, up to August 2018, indexed on the databases of the US National Library of Medicine, Cochrane Central Register of Controlled Trials, Web of Science, and Scientific Electronic Library Online. The sample comprised 10 publications that met the established criteria for inclusion and exclusion, including 2,425 patients who were subjected to mastectomy alone, and 2,772 patients who were subjected to mastectomy associated with immediate reconstruction of the breast. The prevalence of lymphedema was 20.95% in patients who had been subjected to mastectomy alone (n = 508), and 5.23% among those patients who were subjected to mastectomy associated with immediate reconstruction of the breast (n = 145), the difference being statistically significant (p < 0.001). We concluded that mastectomy, when associated with immediate breast reconstruction, has a positive influence on the prognosis of patients living with breast cancer, thereby providing a much lower rate of lymphedema when compared with mastectomy alone.

Humans , Adult , Middle Aged , Aged , Breast Neoplasms/surgery , Mammaplasty/adverse effects , Mammaplasty/methods , Mammaplasty/rehabilitation , Breast Cancer Lymphedema/surgery , Breast Cancer Lymphedema/pathology , Lymphedema/complications
Article in Korean | WPRIM (Western Pacific) | ID: wprim-759748


Elephantiasis nostras verrucosa (ENV) is an uncommon condition caused by repeated inflammation and lymphatic obstruction. It occurs mainly in the lower extremities and is characterized by skin changes, including hyperkeratotic mossy papules and plaques, non-pitting edema, and cobblestone-like appearances. ENV can be diagnosed based on its typical clinical manifestations (pseudoepitheliomatous hyperplasia with enlarged lymphatic spaces, fibrous tissue proliferation, and chronic inflammation) and by skin biopsy. Although ENV is difficult to treat, reduction of lymphedema and use of keratolytic agents may be helpful. To our knowledge, only three cases of ENV have been reported. However, the case of ENV treated with oral acitretin has not been reported in domestic literatures. Therefore, we report the case of a 45-year-old woman who developed ENV. She had a past history of cellulitis and was successfully treated with oral acitretin.

Acitretin , Biopsy , Cellulitis , Edema , Elephantiasis , Female , Humans , Hyperplasia , Inflammation , Keratolytic Agents , Lower Extremity , Lymphedema , Middle Aged , Skin
Cancer Research and Treatment ; : 1041-1051, 2019.
Article in English | WPRIM (Western Pacific) | ID: wprim-763175


PURPOSE: We compared the oncologic outcomes of breast-conserving surgery plus radiation therapy (BCS+RT) and modified radical mastectomy (MRM) under anthracycline plus taxane-based (AT) regimens and investigated the role of adjuvant radiation therapy (RT) in patients with pathologic N1 (pN1) breast cancer treated by mastectomy. MATERIALS AND METHODS: We retrospectively reviewed the medical records of 2,011 patients with pN1 breast cancer who underwent BCS+RT or MRM alone at 12 institutions between January 2006 and December 2010. Two-to-one propensity score matching was performed for balances in variables between the groups. RESULTS: The median follow-up duration for the total cohort was 69 months (range, 1 to 114 months). After propensity score matching, 1,074 patients (676 in the BCS+RT group and 398 in the MRM-alone group) were analyzed finally. The overall survival, disease-free survival, locoregional failure-free survival, and regional failure-free survival (RFFS) curves of the BCS+RT group vs. MRM-alone group were not significantly different. The subgroup analysis revealed that in the group with both lymphovascular invasion (LVI) and histologic grade (HG) III, the BCS+RT showed significantly superior RFFS (p=0.008). Lymphedema (p=0.007) and radiation pneumonitis (p=0.031) occurred more frequently in the BCS+RT group than in the MRM-alone group, significantly. CONCLUSION: There are no differences in oncologic outcomes between BCS+RT and MRM-alone groups under the AT chemotherapy regimens for pN1 breast cancer. However, BCS+RT group showed superior RFFS to MRM-alone group in the patients with LVI and HG III. Adjuvant RT might be considerable for pN1 breast cancer patients with LVI and HG III.

Anthracyclines , Breast Neoplasms , Breast , Cohort Studies , Disease-Free Survival , Drug Therapy , Follow-Up Studies , Humans , Lymphedema , Mastectomy , Mastectomy, Modified Radical , Mastectomy, Segmental , Medical Records , Propensity Score , Radiation Pneumonitis , Retrospective Studies
Article in English | WPRIM (Western Pacific) | ID: wprim-762844


BACKGROUND: Lymphaticovenous anastomosis is an important surgical treatment for lymphedema, with lymphaticovenous side-to-end anastomosis (LVSEA) and lymphaticovenous end-to-end anastomosis being the most frequently performed procedures. However, LVSEA can cause lymphatic flow obstruction because of regurgitation and tension in the anastomosis. In this study, we introduce a novel and simple procedure to overcome this problem. METHODS: Thirty-five female patients with lower extremity lymphedema who underwent lymphaticovenous anastomosis at our hospital were included in this study. Eighty-five LVSEA procedures were performed, of which 12 resulted in insufficient venous blood flow. For these 12 anastomoses, the proximal lymphatic vessel underwent clipping after the anastomotic procedure and the venous inflow was monitored. Subsequently, the proximal ligation after side-to-end anastomosis recovery (PLASTER) technique, which involves ligating the proximal side of the lymphatic vessel, was applied. A postoperative evaluation was performed using indocyanine green 6 months after surgery. RESULTS: Despite the clipping procedure, three of the 12 anastomoses still showed poor venous inflow. Therefore, it was not possible to apply the PLASTER technique in those cases. Among the nine remaining anastomoses in which the PLASTER technique was applied, three (33%) were patent. CONCLUSIONS: Our findings show that achieving patent anastomosis is challenging when postoperative venous inflow is poor. We achieved good results by performing proximal ligation after LVSEA. Thus, the PLASTER technique is a particularly useful recovery technique when LVSEA does not result in good run-off.

Edema , Female , Humans , Indocyanine Green , Ligation , Lower Extremity , Lymphatic Diseases , Lymphatic Vessels , Lymphedema , Microsurgery
Annals of Dermatology ; : S20-S21, 2019.
Article in English | WPRIM (Western Pacific) | ID: wprim-762417


No abstract available.

Humans , Lower Extremity , Lymphedema , Vasculitis
Article in English | WPRIM (Western Pacific) | ID: wprim-739824


OBJECTIVE: To find out whether levels of fibrin degradation products (FDP) and D-dimer are increased in breast cancer-related lymphedema (BCRL) as in many vascular diseases. FDP and D-dimer have been used in blood tests to help differentiate deep vein thrombosis in the diagnosis of lymphedema. Levels of FDP and D-dimer are often elevated in patients with BCRL. METHODS: Patients with BCRL (group I), non-lymphedema after breast cancer treatment (group II), and deep venous thrombosis (group III) from January 2012 to December 2016 were enrolled. Levels of FDP and D-dimer were measured in all groups and compared among groups. RESULTS: Mean values of FDP and D-dimer of group I were 5.614±12.387 and 1.179±2.408 μg/μL, respectively. These were significantly higher than their upper normal limits set in our institution. Levels of FDP or D-dimer were not significantly different between group I and group II. However, values of FDP and D-dimer in group III were significantly higher than those in group I. CONCLUSION: Values of FDP and D-dimer were much higher in patients with thrombotic disease than those in patients with lymphedema. Thus, FDP and D-dimer can be used to differentiate between DVT and lymphedema. However, elevated levels of FDP or D-dimer cannot indicate the occurrence of lymphedema.

Breast Neoplasms , Breast , Diagnosis , Fibrin Fibrinogen Degradation Products , Fibrin , Hematologic Tests , Humans , Lymphedema , Vascular Diseases , Venous Thrombosis
Article in English | WPRIM (Western Pacific) | ID: wprim-785417


OBJECTIVE: To compare the treatment effects, satisfaction with the treatment, and performance improvement following bandage treatment using the spiral method and spica method for breast cancer-related lymphedema (BCRL).METHODS: A prospective study with 46 patients with BCRL was conducted. All patients were divided into either the spiral or spica group for non-elastic bandage therapy and received the same treatment for 2 weeks, apart from the group-specific bandaging method used. For both groups, the Quality of Life Instrument score before treatment, changes in the volume of lymphedema limb and the Disability of the Arm, Shoulder, and Hand (DASH) score before and after treatment, and treatment satisfaction after treatment were compared. The Student t-test was used to compare the parameters between the two different bandage methods.RESULTS: With respect to the treatment outcomes, total volume reduction and proximal part volume reduction after treatment were 98.0±158.3 mL and 56.0±65.4 mL in the spiral method group and 199.0±125.1 mL and 106.1±82.2 mL in the spica method group, respectively. Therefore, the spica method group showed a significantly better improvement (p < 0.05). The DASH score changes after treatment showed that the spiral group score increased by 3.8±5.4 and the spica group score increased by 7.7±6.1; thus, a significantly better improvement was noted in the spica group (p < 0.05).CONCLUSION: The spica method indicated better volume reduction and DASH score improvement than the spiral method. Therefore, the spica method may be more effective for treating patients with BCRL.

Arm , Bandages , Breast , Extremities , Hand , Humans , Lymphedema , Methods , Prospective Studies , Quality of Life , Shoulder
Article in English | WPRIM (Western Pacific) | ID: wprim-785412


Lymphedema, a chronic disease that lowers patients' quality of life, is categorized as primary or secondary. Secondary lymphedema can be improved by treating the underlying cause. However, in many cases, efforts are not made to identify the primary cause of lymphedema and treatment is targeted at the edema itself, resulting in misdiagnosis. Here, we describe the case of a 61-year-old man with right leg edema of unknown cause that had persisted for 3 years. Intestinal tuberculosis was confirmed during a re-evaluation of the cause, and his symptoms improved after anti-tuberculous treatment. This improvement was assessed qualitatively by indocyanine green lymphography before and after treatment, as well as by observation of the clinical symptoms. Lower extremity lymphedema caused by intestinal tuberculosis is extremely rare, and this case reveals the importance of continuing to identify the causes of resistant pathologies.

Chronic Disease , Diagnostic Errors , Edema , Humans , Indocyanine Green , Leg , Lower Extremity , Lymphedema , Lymphography , Middle Aged , Pathology , Quality of Life , Tuberculosis
Article in Chinese | WPRIM (Western Pacific) | ID: wprim-775047


An 11-year-old girl was found to have pale complexion and anemia with gradual aggravation for one year. She was weak in the past and developed pneumonia in the right middle lung 3-5 times per year, which was improved after anti-infective therapy. She and her mother had congenital deaf-mutism. Physical examination showed the appearance of anemia, without bleeding, jaundice, hepatosplenomegaly, or lymph node enlargement. Routine blood test results showed reductions in all three blood cell lines, normocytic anemia, and megaloblastoid change in granulocytic and erythroid cell lines in bone marrow, with no obvious increase in primitive cells or metastatic tumor cells. Whole exome sequencing indicated the presence of a known pathogenic mutation for Emberger syndrome (ES), c.1084C>T (p.Arg362*) in the GATA2 gene. The girl was finally diagnosed with ES, and myelodysplastic syndrome (MDS) progressed to acute myeloid leukemia during follow-up. ES is a rare type of MDS with autosomal dominant inheritance in clinical practice, and it is difficult to make a confirmed diagnosis. ES should be considered for children with unexplained lymphedema and congenital deafness, and gene detection should be performed to make a confirmed diagnosis.

Anemia , Child , Female , GATA2 Transcription Factor , Humans , Lymphedema , Mutism , Myelodysplastic Syndromes
J. vasc. bras ; 18: e20190015, 2019. ilus
Article in Portuguese | LILACS (Americas) | ID: biblio-1012620


Algumas infecções virais sistêmicas podem estar relacionadas ao desenvolvimento de complicações vasculares, como trombose venosa profunda e linfedema de membros inferiores e superiores. Essa relação já está bem estabelecida em pacientes portadores do vírus da imunodeficiência humana (HIV), hepatite C ou influenza. Recentemente introduzido no continente americano (2013), o vírus chicungunha, um arbovírus transmitido pelo mosquito do gênero Aedes e agente etiológico da febre chicungunha (FC), ainda não tem essa relação bem sedimentada. Porém, o surto de FC, ocorrido entre 2015 e 2016, fez com que fossem descritos na literatura médica os primeiros casos de complicações vasculares agudas e crônicas secundárias à infecção por essa arbovirose. Neste relato de caso, descrevemos uma paciente que desenvolveu linfedema de membros superiores e inferiores após quadro de FC

Certain systemic viral infections can be related to development of vascular complications, such as deep venous thrombosis and lymphedema of lower and upper limbs. These links have been well-established in patients with human immunodeficiency virus (HIV), hepatitis C, or influenza. Recently introduced into the American continent (2013), chikungunya virus is an arbovirus transmitted by mosquitoes of the Aedes genus and is the etiologic agent of chikungunya fever (CF), but its relationship to these vascular complications has not yet been consolidated. However, the CF outbreak that occurred during 2015 and 2016 resulted in the first cases described in the medical literature of acute and chronic vascular complications secondary to infection by this arbovirus. In this report, we describe the case of a patient who developed lymphedema of upper and lower limbs after an episode of CF

Humans , Female , Adult , Lower Extremity , Chikungunya Fever/complications , Lymphedema , Arbovirus Infections , Chikungunya virus , Chronic Disease , Upper Extremity , Infections
J. vasc. bras ; 18: e20180066, 2019. tab, graf
Article in Portuguese | LILACS (Americas) | ID: biblio-1002488


O linfedema de membros inferiores é uma doença crônica decorrente de dano no sistema linfático que influencia a mobilidade, a funcionalidade e a qualidade de vida dos indivíduos. Questionários e o teste físico são métodos bastante práticos, de fácil aplicação e baixo custo, que fornecem dados importantes para a avaliação desses pacientes. Objetivos Avaliar a influência do linfedema unilateral de membro inferior na funcionalidade e na qualidade de vida, correlacionando três ferramentas de avaliação. Métodos Estudo descritivo com 25 indivíduos com linfedema unilateral em membro inferior, de ambos os sexos. Foi avaliada a perimetria e foram aplicados The Medical Outcome Study Short Form-36 Health Survey (SF-36) para avaliação da qualidade de vida, Lymphoedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphoedema (Lymph-ICF-LL) para estudo das habilidades físicas, mentais e sociais relacionadas ao linfedema e o Timed Up and Go (TUG) para avaliação da funcionalidade. Resultados Houve a presença de linfedema em todo o membro inferior dos participantes. Os domínios mais prejudicados pelo linfedema foram os aspectos físicos (25,0 ± 31,4) e emocionais (36,0 ± 42,9) no SF-36 e o domínio mobilidade (6,0 ± 2,6) no Lymph-ICF-LL. O TUG foi realizado em 9,88 ± 1,98 s. Houve correlação entre o TUG e os questionários e entre os dois questionários utilizados. Conclusões Indivíduos com linfedema unilateral em membro inferior apresentam um impacto negativo na qualidade de vida e na funcionalidade avaliadas através de questionários, que correlacionam entre si. Não foi encontrada alteração no TUG, mas houve correlação entre ele e os questionários utilizados

Lymphedema of the lower limbs is a chronic disease caused by damage to the lymphatic system that influences people's mobility, functionality, and quality of life. Questionnaires and physical test are very practical, easy to apply, and low cost methods that provide important data for evaluation of these patients. Objectives To evaluate the influence of unilateral lower limb lymphedema on functionality and quality of life, correlating 3 assessment tools. Methods This was a descriptive study investigating 25 patients of both sexes with unilateral lymphedema in a lower limb. Limb volume was assessed using circumferential tape measurements, the Medical Outcomes Study Short Form-36 Health Survey (SF-36) was used to assess quality of life, the Lymphoedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphoedema (Lymph-ICF-LL) was used to assess physical, mental, and social skills related to lymphedema, and the Timed Up and Go (TUG) test was used for functional assessment. Results Lymphedema was present throughout the affected lower limb of participants. The domains most affected by lymphedema were physical aspects (25.0 ± 31.4) and emotional aspects (36.0 ± 42.9) from the SF-36 and the mobility domain (6.0 ± 2.6) from the Lymph -ICF-LL. Patients performed the TUG in 9.88 ± 1.98 seconds. The TUG was correlated with the questionnaires and the questionnaires were correlated with each other. Conclusions People with unilateral lower limb lymphedema exhibited negative impacts on quality of life and functionality, as evaluated by questionnaires, which were correlated with each other. TUG performance was within normal limits, but results correlated with the questionnaires used

Humans , Male , Female , Adult , Middle Aged , Quality of Life , Lower Extremity , Lymphedema/complications , Lymphedema/diagnosis , Comorbidity , Sex Factors , Chronic Disease , Epidemiology, Descriptive , Statistical Analysis , Surveys and Questionnaires , Age Factors , Physical Therapy Specialty/methods , Diabetes Mellitus , Hypertension , Lymphatic System , Obesity
Article in Portuguese | LILACS (Americas) | ID: biblio-1026432


Introdução: O linfedema relacionado ao câncer de mama é a principal complicação dos tratamentos para essa neoplasia, acometendo o membro superior homolateral à mama comprometida. Objetivo: Analisar a incidência, fatores de risco e o impacto na sobrevida global do linfedema secundário ao câncer de mama. Método: Estudo de coorte retrospectivo com dados de 709 mulheres atendidas em núcleo de reabilitação de câncer de mama, entre 1989 e 2014. Realizou-se comparação de frequências absolutas categóricas com o teste qui-quadrado. As funções de sobrevida foram calculadas por meio do método de Kaplan Meier e o modelo de riscos proporcionais de Cox foi utilizado para avaliação de fatores prognósticos; utilizou-se a regressão logística para definir fatores associados à incidência de linfedema. Resultados: Predominaram mulheres brancas, média de idade de 61,5 anos. Das mulheres com linfedema (33,24%), 85,8% foram diagnosticadas em estadiamento avançado, maior frequência de linfadenectomia axilar (p=0,064) e baixa realização da biópsia de linfonodo sentinela (p<0,0001). No status de sobrevida, as mulheres com linfedema apresentaram maior frequência de óbito por causas relacionadas ao câncer (50,2%), com taxa de sobrevivência de 0,996 até cinco anos. As principais características preditoras ao óbito dessas mulheres foram o estadiamento avançado e a quantidade de linfonodos comprometidos. Conclusão: As mulheres com linfedema apresentaram maior chance de óbito por câncer do que o outro grupo, porém permaneceram vivas por período maior. O estadiamento avançado e a não realização da biópsia do linfonodo sentinela foram considerados fatores de risco para o desenvolvimento do linfedema e como características preditoras de óbito.

Introduction: Lymphedema related to breast cancer is the main complication of the treatments for this neoplasm, affecting the upper limb homolateral to the compromised breast. Objective: To analyze the incidence, risk factors and impact on overall survival of lymphedema secondary to breast cancer. Method: Retrospective cohort study with 709 women attended at a rehabilitation center for breast cancer, between 1989 and 2014. The categorical absolute frequencies were compared to the Chi-square test. Overall survival rate was calculated using Kaplan Meier method and the Cox proportional hazard regression model was used to evaluation of prognostic factors, the definition of indicators associated with lymphedema incidence was calculated with logistic regression. Results: White women predominated, mean age 61.5 years. Women with lymphedema (33.24%), 85.8% were diagnosed at an advanced stage, a higher frequency of axillary lymphadenectomy (p=0.064) and low sentinel lymph node biopsy (p<0.0001). In the survival status the women with lymphedema presented a higher death rate due to the cancer (50.2%), with a survival rate of 0.996 up to five years. Women death predictors were advanced cancer stage and the amount of compromised lymph nodes. Conclusion: Women with lymphedema present a greater chance to die from cancer than the other group, but they remain alive for a longer period. The advanced stage and non-performance of sentinel lymph node biopsy were considered risk factors for the development of lymphedema and the predictive characteristics of death.

Introducción: El linfedema relacionado con el cáncer de mama es la principal complicación de los tratamientos para esta neoplasia, afectando al miembro superior homolateral a la mama comprometida. Objetivo:Analizar la incidencia, factores de riesgo y impacto en la supervivencia global del linfedema secundario al cáncer de mama. Método: Estudio de cohorte retrospectivo con 709 mujeres atendidas en un núcleo de rehabilitación de cáncer, entre 1989 y 2014. Se realizó la comparación de sus series completas con la prueba Chi-cuadrado. Funciones de sobrevida fueran calculadas por método de Kaplan Meier y el modelo de evaluación de Cox fue utilizado para la evaluación de factores pronósticos, regresión logística fue usada para la definición de indicadores asociados al incidencia de linfedema. Resultados:Predominaron mujeres blancas, media de edad 61,5 años. Las mujeres con linfedema (33,24%), 85,8% fueron diagnosticadas en estadio avanzado, mayor frecuencia de linfadenectomía axilar (p=0,064) y baja realización de la biopsia de ganglio centinela (p<0,0001). En el estatus de sobrevida, mujeres con linfedema presentaron mayor frecuencia de muerte por cáncer (50,2%), con tasa de supervivencia de 0,996 hasta cinco años. Las características predictoras de muerte fueran estadio avanzado y la cantidad de ganglios linfáticos comprometidos. Conclusión: Las mujeres con linfedema presentan mayor probabilidad de muerte por cáncer que el otro grupo, sin embargo, permanecen vivas por período mayor. El estado avanzado y la no realización de la biopsia del ganglio centinela fueron considerados factores de riesgo para el desarrollo del linfedema y como características preditorias del óbito.

Humans , Female , Breast Neoplasms/complications , Survival Analysis , Breast Cancer Lymphedema/epidemiology , Risk Factors , Breast Cancer Lymphedema/prevention & control , Lymphedema/mortality
Article in English | WPRIM (Western Pacific) | ID: wprim-742333


Gorham-Stout disease (GSD) was first described by Gorham and colleagues in 1954, but its precise mechanism and cause remain to be elucidated. In this condition, voluminous and potentially fatal chylous effusions into the thorax can occur. Herein, we describe a case of GSD in which the patient presented with massive pleural effusions and mottled osteolytic bone lesions. We performed multiple operations, including thoracic duct ligation using video-assisted thoracoscopic surgery and thoracotomic decortication, but these procedures did not succeed in preventing recurrent pleural effusion and chest wall lymphedema. After administering sirolimus (0.8 mg/m2, twice a day) and propranolol (40 mg, twice a day), the process of GSD in this patient has been controlled for more than 2 years.

Chylothorax , Humans , Ligation , Lymphedema , Osteolysis, Essential , Pleural Effusion , Propranolol , Sirolimus , Thoracic Duct , Thoracic Surgery, Video-Assisted , Thoracic Wall , Thorax
Rev. chil. cir ; 70(6): 589-597, dic. 2018. tab, ilus
Article in Spanish | LILACS (Americas) | ID: biblio-978034


El linfedema es la acumulación de fluido rico en proteínas en el intersticio, secundario a anomalías en el sistema de transporte linfático. En países desarrollados se relaciona más frecuentemente al tratamiento quirúrgico del cáncer. El diagnóstico clínico y a través de técnicas de imágenes es fundamental para evaluar el estado funcional del sistema linfático. Los objetivos principales en el manejo del linfedema son limitar la morbilidad del paciente, mejorar la funcionalidad y la calidad de vida. El tratamiento quirúrgico es una alternativa cuando las medidas conservadoras ya no son suficientes. Existen procedimientos que buscan prevenir el desarrollo del linfedema y técnicas que incluye procedimientos fisiológicos (reconstructivos) y resectivos que se utilizan cuando el linfedema ya está establecido. El éxito depende de una buena elección de los pacientes y la realización de un tratamiento individualizado. A continuación se presenta una revisión en cuanto a las últimas estrategias diagnósticas y actualización en las técnicas quirúrgicas con énfasis en el tratamiento microquirúrgico.

Lymphedema is the accumulation of protein-rich fluid in the interstitium, secondary to abnormalities in the lymphatic transport system. In developed countries it is more often related to surgical treatment of cancer. The clinical diagnosis and through imaging techniques is fundamental to evaluate the functional status of the lymphatic system. The main objectives in managing lymphedema are to limit patient morbidity, improve functionality and quality of life. Surgical treatment is an option when conservative measures are no longer sufficient. There are procedures that seek to prevent the development of lymphedema, and techniques that include physiological (reconstructive) and resective procedures that are used when lymphedema is already established. Success depends on a good selection of patients and the completion of an individualized treatment. The following is a review article of the latest diagnostic strategies and update in surgical techniques with emphasis on microsurgical treatment.

Humans , Lymphedema/surgery , Lymphedema/diagnostic imaging , Veins/surgery , Anastomosis, Surgical , Magnetic Resonance Imaging , Lymphography , Contrast Media , Lymphatic Vessels/surgery , Lymphoscintigraphy , Indocyanine Green , Lymph Nodes/blood supply , Lymph Nodes/transplantation , Lymphedema/therapy , Microsurgery
Rev. patol. trop ; 47(1): 55-66, març. 2018. tab, graf
Article in English | LILACS (Americas) | ID: biblio-913764


Lymphatic filariasis affects millions of people around the world and may have disabling consequences. Lymphedema stands out as a chronic manifestation in patients with this disease, affecting the lower limbs and limiting motor function. This study aimed to propose a treatment protocol to decrease lower limb lymphedema of treated patients and to show the efficacy of Complex Decongestive Therapy (CDT) as an auxiliary resource for this condition. This is a case study of a patient treated with CDT, making use of compression methods with alternative materials and instructions for asepsis during 10 weeks. The results demonstrated that this treatment reduced lymphedema in the right lower limb of the patient from grade V to grade III, with areas of measurement reduction of up to 41%. In addition, acute dermatolymphangioadenitis (ADLA) manifestations stopped in the treated patient. CDT associated with low-cost compression material, has been shown to be effective in reducing lower limb lymphedema and ADLA crises, as well as in promoting improved locomotion and performance of daily activities by the patient

Elephantiasis , Filariasis , Lymphedema
Article in English | WPRIM (Western Pacific) | ID: wprim-739808


Hennekam syndrome is a rare autosomal recessive disorder resulting from malformation of the lymphatic system. The characteristic signs of Hennekam syndrome are lymphangiectasia, lymph edema, facial anomalies, and mental retardation. This is a case in which a patient presented with left-arm lymphedema, facial-feature anomalies, and multiple organ lymphangiectasia consistent with symptoms of Hennekam syndrome. There is no curative therapy at this time, but rehabilitative treatments including complete decongestive therapy for edema control appeared to be beneficial.

Edema , Humans , Intellectual Disability , Lymphatic System , Lymphedema
Clinical Pain ; (2): 119-122, 2018.
Article in English | WPRIM (Western Pacific) | ID: wprim-786706


Rheumatoid lymphedema (RL) is a rare complication of rheumatoid arthritis (RA). The pathophysiology of RL is not yet fully understood, and the management is also not standardized. As yet, there is low awareness regarding RL and complex decongestive physical therapy (CDPT) among physicians; hence, diagnosis and treatment are delayed. A few studies have reported the positive effects of tumor necrosis factor-α inhibitory drugs on RL. CDPT is still considered the gold standard for the treatment of cancer-related lymphedema, but there are few reports on the effects of CDPT on RL. Therefore, we report two cases of chronic International Society of Lymphology lymphedema stage II RL that exhibited good therapeutic outcomes after CDPT. One of the two patient had taken a tumor necrosis factor-α inhibitory drug, but RL still has progressed. However, CDPT with multilayer bandage showed significant reduction in the pain and edema of the lower extremities.

Arthritis, Rheumatoid , Bandages , Compression Bandages , Diagnosis , Edema , Humans , Lower Extremity , Lymphedema , Necrosis
Article in English | WPRIM (Western Pacific) | ID: wprim-719043


Breast cancer related lymphedema (BCRL) is one of the most intractable complications after surgery. Patients suffer from physical impairment, as well as psychological depression. Moreover, a recent study revealed that cellulitis significantly increased the risk of BCRL, and cellulitis has been suggested as a risk factor of BCRL development. We describe a patient treated with stellate ganglion blocks (SGBs) without steroid for relief of symptoms and reduction of the arm circumference of breast cancer-related infectious lymphedema in a month. We measured the arm circumference at four locations; 10 cm and 5 cm above and below the elbow crease, numeric rating scale (NRS) score, lymphedema and breast cancer questionnaire (LBCQ) score on every visit to the pain clinic. A serial decrease of the arm circumference and pain score were observed after second injection. In the middle of the process, cellulitis recurred, we performed successive SGBs to treat infectious lymphedema. The patient was satisfied with the relieved pain and swelling, especially with improved shoulder range of motion as it contributes to better quality of life. This case describes the effects of SGB for infectious BCRL patients. SGB could be an alternative or ancillary treatment for infectious BCRL patients.

Arm , Breast Neoplasms , Breast , Cellulitis , Depression , Elbow , Humans , Lymphedema , Pain Clinics , Quality of Life , Range of Motion, Articular , Risk Factors , Shoulder , Stellate Ganglion
Asian Oncology Nursing ; : 143-153, 2018.
Article in Korean | WPRIM (Western Pacific) | ID: wprim-717244


PURPOSE: This study aimed to develop and evaluate the lower extremity lymphedema nursing practice protocol for patients following gynecologic cancer treatment. METHODS: Thirteen web-sites were searched for eligible clinical practice guidelines (CPGs) and eleven databases were searched to identify evidence to develop a lower extremity lymphedema nursing practice protocol for patients following gynecologic cancer treatment. RESULTS: Based on the inclusion and exclusion criteria, eight CPGs and ninety-six studies, two guidelines and eight studies were identified as evidence. The protocol development group consisted of ten experts who have at least five years' experience in the related area. A lower extremity lymphedema nursing practice protocol for patients following gynecologic cancer treatment was developed including forty-three recommendations in five domains. Significant differences were found in nurses' pre and post knowledge and confidence on lower extremity lymphedema prevention and management. CONCLUSION: Nurses and other professionals could utilize this evidence based lower extremity lymphedema nursing practice protocol and apply it to patients undergoing gynecologic cancer treatment.

Female , Genital Neoplasms, Female , Humans , Lower Extremity , Lymphedema , Nursing Assessment , Nursing